4 June 2019 PAINT Conference Call: Difference between revisions

From GO Wiki
Jump to navigation Jump to search
mNo edit summary
No edit summary
Line 5: Line 5:
* '''ACTION ITEM''': Dustin: For the PANTHER 14 release they will produce a table with the diff of number of annotations per family between Panther13 and Panther14.
* '''ACTION ITEM''': Dustin: For the PANTHER 14 release they will produce a table with the diff of number of annotations per family between Panther13 and Panther14.


*'''ACTION ITEM''' Anushya: Remove 'protein binding' from terms we can propagate in PAINT.  
*'''ACTION ITEM''' Anushya: Remove 'protein binding' from terms we can propagate in PAINT.
*'''ACTION ITEM''' Anushya: Import IKR annotations to the annotation matrix and treat them the same as IDA.




Line 11: Line 12:
===Protein binding annotations===
===Protein binding annotations===
We still have > 300 annotations.  
We still have > 300 annotations.  
===Propagate IBAs to genes that have experimental annotations===
There are lots of push backs from the consortium. Do we want to still do it. If so, should we have some rules, for example:
* experimental vs. non experimental.
* conflict annotations (NOT).


[[Category:PAINT]]
[[Category:PAINT]]

Revision as of 11:59, 4 June 2019


Action items from last call:

  • ACTION ITEM: Dustin: For the PANTHER 14 release they will produce a table with the diff of number of annotations per family between Panther13 and Panther14.
  • ACTION ITEM Anushya: Remove 'protein binding' from terms we can propagate in PAINT.
  • ACTION ITEM Anushya: Import IKR annotations to the annotation matrix and treat them the same as IDA.


Discussion

Protein binding annotations

We still have > 300 annotations.

Propagate IBAs to genes that have experimental annotations

There are lots of push backs from the consortium. Do we want to still do it. If so, should we have some rules, for example:

  • experimental vs. non experimental.
  • conflict annotations (NOT).